Related Experiment Videos
Cognitive behaviour therapy for schizophrenia.
1Department of Clinical Psychology, School of Psychology, University of Birmingham, Edgbeston, Birmingham, UK, B15 2TT.
The Cochrane Database of Systematic Reviews
|May 5, 2000
Summary
Cognitive Behaviour Therapy (CBT) significantly reduces relapse rates in schizophrenia patients when added to standard care. However, access to this therapy is limited by the availability of experienced practitioners.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Medication is primary for schizophrenia, but talking therapies are also indicated.
- Cognitive Behaviour Therapy (CBT) links thoughts, feelings, and distress patterns.
Purpose of the Study:
- Review CBT effects for schizophrenia vs. standard care, medication, and non-intervention.
- Assess CBT's impact alongside standard care versus other interventions.
Main Methods:
- Searched multiple databases (1980-1998) for randomized trials on CBT for schizophrenia.
- Included outcomes like mortality, mental state, relapse, well-being, and treatment acceptability.
Main Results:
- Four small trials indicated CBT plus standard care reduced relapse rates (short, medium, long-term).
- CBT did not improve retention in care, and medication compliance data was absent.
- CBT showed no statistically significant advantage over supportive psychotherapy in one underpowered study.
Conclusions:
- Ongoing trials are needed to confirm findings.
- CBT access for schizophrenia is linked to reduced relapse but is limited by therapist availability.
- Effectiveness of CBT by less experienced practitioners is currently unknown.